| abstract |
The present invention relates to the use of selected DPP-IV inhibitors to treat physiological dysfunction and to reduce the risk of a group of patients at risk for exhibiting such dysfunction. In addition, the use of the DPP-IV inhibitor is described which can be used in combination with other agents to obtain improved therapeutic results. Such uses may be used to prepare corresponding medicaments. |